Patents by Inventor Kamyar Kalantar-Zadeh

Kamyar Kalantar-Zadeh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING RENAL DISEASE
    Publication number: 20210267959
    Abstract: Disclosed herein, inter alia, are methods of treating renal disease (e.g., chronic kidney disease or end stage renal disease).
    Type: Application
    Filed: July 16, 2019
    Publication date: September 2, 2021
    Inventors: Hamid MORADI, Daniele PIOMELLI, Kamyar KALANTAR-ZADEH
  • Prognostic assays for maintenance hemodialysis patients
    Patent number: 10473675
    Abstract: Described herein are methods for determining the overall survival of maintenance hemodialysis patients. The methods include measuring low density lipoprotein (LDL) particle size and subfraction concentrations as prognostic tools for early mortality risk detection. For example, the presence of increased very small LDL concentration or decreased LDL particle size in blood-serum serves as a useful means for prognostic risk assessment and monitoring.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: November 12, 2019
    Assignees: Quest Diagnostics Investments Incorporated, Los Angeles Biomedical Research Institute
    Inventors: Kamyar Kalantar-Zadeh, Michael P. Caulfield, Wael A. Salameh
  • PROGNOSTIC ASSAYS FOR MAINTENANCE HEMODIALYSIS PATIENTS
    Publication number: 20170343568
    Abstract: Described herein are methods for determining the overall survival of maintenance hemodialysis patients. The methods include measuring low density lipoprotein (LDL) particle size and subfraction concentrations as prognostic tools for early mortality risk detection. For example, the presence of increased very small LDL concentration or decreased LDL particle size in blood-serum serves as a useful means for prognostic risk assessment and monitoring.
    Type: Application
    Filed: April 7, 2017
    Publication date: November 30, 2017
    Applicants: Quest Diagnostics Investments Incorporated, Los Angeles Biomedical Research Institute
    Inventors: Kamyar Kalantar-Zadeh, Michael P. Caulfield, Wael A. Salameh
  • Prognostic assays for maintenance hemodialysis patients
    Patent number: 9638705
    Abstract: Described herein are methods for determining the overall survival of maintenance hemodialysis patients. The methods include measuring low density lipoprotein (LDL) particle size and subfraction concentrations as prognostic tools for early mortality risk detection. For example, the presence of increased very small LDL concentration or decreased LDL particle size in blood-serum serves as a useful means for prognostic risk assessment and monitoring.
    Type: Grant
    Filed: October 27, 2011
    Date of Patent: May 2, 2017
    Assignees: QUEST DIAGNOSTICS INVESTMENTS INCORPORATED, LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE
    Inventors: Kamyar Kalantar-Zadeh, Michael P. Caulfield, Wael A. Salameh
  • PROGNOSTIC ASSAYS FOR MAINTENANCE HEMODIALYSIS PATIENTS
    Publication number: 20120103072
    Abstract: Described herein are methods for determining the overall survival of maintenance hemodialysis patients. The methods include measuring low density lipoprotein (LDL) particle size and subfraction concentrations as prognostic tools for early mortality risk detection. For example, the presence of increased very small LDL concentration or decreased LDL particle size in blood-serum serves as a useful means for prognostic risk assessment and monitoring.
    Type: Application
    Filed: October 27, 2011
    Publication date: May 3, 2012
    Inventors: Kamyar Kalantar-Zadeh, Michael P. Caulfield, Wael A. Salameh